In English | En español
Questions About Cancer? 1-800-4-CANCER

Clinical Trials Search Results

Clinical Trials Search Results

Initial search results include only NCI-sponsored clinical trials. To search all trials, click the "REFINE SEARCH" button, scroll down to the Trial ID/Sponsor section and select the "All" check box in the Sponsor of Trial section.

View Content for:
Display:
  •          
Help with display options.
Results 1-25 of 44 for your search:
Drug:  cladribine
Find trials that include:  Any drugs shown
Trial Status:  Closed
Start Over
        Show
1.

Phase: Phase IV
Type: Treatment
Status: Completed
Age: 15 to 65
Sponsor: Other
Protocol IDs: GMALL04, NCT00199017

2.

Phase: Phase III
Type: Treatment
Status: Closed
Age: 18 to 79
Sponsor:
Protocol IDs: EORTC-06942

3.

Phase: Phase III
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: Other
Protocol IDs: SAKK 32/98, SWS-SAKK-32/98, EU-98074, NCT00003746

4.

Phase: Phase II, Phase I
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor: NCI
Protocol IDs: NU-93H4, NCI-G99-1635

5.

Phase: Phase II, Phase I
Type: Supportive care
Status: Closed
Age: 5 to 50
Sponsor: NCI
Protocol IDs: FHCRC-126.8, NCI-T91-0013D, T91-0013

6.

Phase: Phase II, Phase I
Type: Treatment
Status: Completed
Age: 17 and over
Sponsor:
Protocol IDs: MSKCC-91094, NCI-V91-0185

7.

Phase: Phase II, Phase I
Type: Biomarker/Laboratory analysis, Treatment
Status: Closed
Age: 18 to 85
Sponsor: NCI, Other
Protocol IDs: CDR0000615128, P30CA069533, OHSU-4180, HEM-08002-L, MERCK-OHSU-4180, 4180, OHSU-HEM-08002-L, NCT00764517

8.

Phase: Phase II, Phase I
Type: Biomarker/Laboratory analysis, Treatment
Status: Closed
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: CDR0000619329, NCCTG-N078D, N078D, NCT00787969

9.

Phase: Phase II
Type: Treatment
Status: Closed
Age: 18 to 70
Sponsor:
Protocol IDs: SWS-SAKK-39/93, EU-93012

10.

Phase: Phase II
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor: NCI
Protocol IDs: NCCTG-938151, NCCTG-93-81-51

11.

Phase: Phase II
Type: Treatment
Status: Closed
Age: over 18
Sponsor:
Protocol IDs: UCCRC-7154, NCI-V94-0451

12.

Phase: Phase II
Type: Treatment
Status: Closed
Age: over 18
Sponsor:
Protocol IDs: MSKCC-94038, NCI-V94-0475

13.

Phase: Phase II
Type: Treatment
Status: Closed
Age: any age
Sponsor:
Protocol IDs: SWS-SAKK-32/93, EU-94037

14.

Phase: Phase II
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor: Other
Protocol IDs: NU-LE94-52-005, NCI-V95-0666

15.

Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Status: Completed
Age: under 22
Sponsor: NCI, Other
Protocol IDs: 2951, CCG-2951, CDR0000064907, NCT00002805

16.

Phase: Phase II
Type: Treatment
Status: Completed
Age: 55 to 70
Sponsor: NCI, Other
Protocol IDs: DM94-078, P30CA016672, MDA-DM-94078, NCI-G96-1001, CDR0000065035, NCT00002833

17.

Phase: Phase II
Type: Treatment
Status: Closed
Age: no age specified
Sponsor: NCI
Protocol IDs: E-5995, E5995

18.

Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: CDR0000065179, NCCTG-958053, NCT00002879

19.

Phase: Phase II
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI
Protocol IDs: NCCTG-958151, NCCTG-95-81-51

20.

Phase: Phase II
Type: Treatment
Status: Completed
Age: Under 21 at diagnosis
Sponsor: NCI, Other
Protocol IDs: 9720, COG-P9720, POG-9720, CDR0000065993, NCT00003178

21.

Phase: Phase II
Type: Treatment
Status: Closed
Age: 18-75
Sponsor:
Protocol IDs: SWS-SAKK-37/95, EU-97040

22.

Phase: Phase II
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor:
Protocol IDs: SWS-SAKK-32/95, EU-97039

23.

Phase: Phase II
Type: Treatment
Status: Closed
Age: 16 and over
Sponsor:
Protocol IDs: MDA-DM-88083, NCI-V89-0246

24.

Phase: Phase II
Type: Treatment
Status: Closed
Age: over 18
Sponsor: NCI
Protocol IDs: CLB-9153, CALGB-9153

25.

Phase: Phase II
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor: NCI
Protocol IDs: CLB-9211, CALGB-9211
1   
New Search